DNA定序的全球市场:研究、应用与临床市场
市场调查报告书
商品编码
1621139

DNA定序的全球市场:研究、应用与临床市场

Global DNA Sequencing: Research, Applied and Clinical Markets

出版日期: | 出版商: BCC Research | 英文 168 Pages | 订单完成后即时交付

价格

预计到 2029年终,全球 DNA定序市场规模将达到 348 亿美元,预测期内复合年增长率为 18.6%,而 2024 年为 148 亿美元。

北美市场预计将从 2024 年的 70 亿美元成长到 2029年终的164 亿美元,预测期内复合年增长率为 18.8%。欧洲市场预计将从2024年的38亿美元成长到2029年终的88亿美元,复合年增长率为18.5%。

该报告调查了全球 DNA定序市场,并提供了市场概况、市场影响因素和市场机会、法律制度、新兴技术和技术发展趋势、市场规模趋势和预测、各个细分市场和地区的分析。 、竞争格局、主要企业概况等。

目录

第一章执行摘要

  • 市场展望
  • 调查范围
  • 市场分析

第二章 市场概况

  • DNA 的重要性
  • 遗传变异与分析
  • 定序的历史
  • NGS(二代定序)
  • TGS(长读长定序)
  • 研究与应用
  • 研发用途
  • 应用领域
  • 直接面向消费者的销售
  • 生物製药
  • 农业
  • 法医学
  • 微生物组
  • 合成生物学

第三章市场动态

  • 市场动态简介
  • 市场驱动因素
  • 定序技术的技术进步
  • DNA定序在临床诊断的应用不断增加
  • 市场限制因素
  • DNA序列分析高成本
  • 资料解释与管理挑战
  • 市场机会
  • 精准医疗的扩展
  • NIPT 的成长

第四章新兴技术

  • 长读长定序技术
  • SMRT序列
  • 奈米孔定序
  • 空间基因组学和转录组学
  • 单细胞DNA定序
  • 超低输入序列
  • 将 CRISPR-Cas9 与基因组编辑和定序技术结合
  • DNA定序中的人工智慧和机器学习

第五章市场区隔分析

  • 细分细分
  • 全球 DNA定序市场分析:依产品和服务分类
  • 设备及用品
  • 服务
  • 全球 DNA定序序市场分析:依技术分类
  • 次世代定序
  • TGS
  • 桑格序列
  • 焦磷酸测序
  • 全球 DNA定序市场分析:依应用分类
  • 生物製药
  • 微生物学
  • 农业
  • 其他(合成生物学、群体基因体学、消费者基因体学)
  • 全球 DNA定序市场分析:依最终用户分类
  • 市场规模及预测
  • 学术研究所
  • 医院/诊所
  • 製药和生物技术公司
  • 临床研究
  • 其他(农业机构、法医学研究所)
  • 全球 DNA定序序市场分析:依疾病类别
  • 市场规模及预测
  • 癌症
  • 生殖健康
  • 孟德尔遗传疾病
  • 其他(心臟科、代谢/免疫学、神经病学、移植、临床)
  • 地域分布
  • 全球 DNA定序序市场分析:按地区
  • 市场规模及预测
  • 北美洲
  • 欧洲
  • 亚太地区
  • 其他领域

第六章 竞争状况

  • 概述
  • 伙伴关係
  • 投资金筹措
  • 专利分析

第 7 章 ESG 观点

  • 市场ESG表现
  • DNA定序产业的ESG实践
  • 环境绩效
  • 社会表现
  • 管治绩效
  • DNA定序产业的ESG风险评估
  • BCC的结语

第8章附录

  • 调查方法
  • 来源
  • 简称
  • 公司简介
  • AGILENT TECHNOLOGIES INC.
  • BGI
  • F. HOFFMANN-LA ROCHE LTD.
  • GUARDANT HEALTH
  • ILLUMINA INC.
  • MYRIAD GENETICS INC.
  • OXFORD NANOPORE TECHNOLOGIES PLC.
  • PACBIO
  • QIAGEN
  • THERMO FISHER SCIENTIFIC INC.
  • Other Key Companies Offering DNA Sequencing Services
  • 10X GENOMICS
  • CROWN BIOSCIENCE
  • EUROFINS GENOMICS
  • GENEWIZ, FROM AZENTA LIFE SCIENCES
  • INTEGRATED DNA TECHNOLOGIES, INC
  • MACROGEN
  • NOVOGENE CO., LTD.
  • REVVITY
Product Code: BIO045J

The global market for DNA sequencing is expected to grow from $14.8 billion in 2024 and is projected to reach $34.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 18.6% during the forecast period of 2024 to 2029.

The North American DNA sequencing market is expected to grow from $7.0 billion in 2024 and is projected to reach $16.4 billion by the end of 2029, at a CAGR of 18.8% during the forecast period of 2024 to 2029. 

The European DNA sequencing market is expected to grow from $3.8 billion in 2024 and is projected to reach $8.8 billion by the end of 2029, at a CAGR of 18.5% during the forecast period of 2024 to 2029.

Report Scope

The report highlights the current and future market potential of DNA sequencing and provides a detailed analysis of market drivers, restraints and opportunities. The report also gives market projections for 2029 and includes a competitive environment and product analysis. The report provides market estimates and forecasts for DNA sequencing based on technology, product & service, end user, application, disease category, and region. By technology, the market is segmented into next-generation sequencing (NGS), third-generation sequencing (TGS), pyrosequencing, and Sanger sequencing. By product and service, the market is categorized into instruments and consumables or services. By end user, the market is segmented into academic and research institutes, hospitals and clinics, pharmaceutical and biotechnology companies, contract research organizations, and others. By application, the market is categorized as biopharma, microbiology, agriculture, or others. By disease category, the market is segmented into cancer, reproductive health, Mendelian disorders, and others. The report includes the company profiles of the key players, with detailed information about their business segments, financials, product portfolios, and recent developments.

By geographical region, the market has been segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). The North American region includes the U.S., Canada and Mexico. Europe includes Germany, the U.K., Italy, France, Spain, and the Rest of Europe; Asia-Pacific includes China, Japan, India, Australia, South Korea, and the Rest of Asia-Pacific. For market estimates, data has been provided for 2021 and 2022 as the historic years and for 2023 as the base year, with forecasts through 2029.

Report Includes

  • 70 data tables and 59 additional tables
  • An overview of the global market for DNA sequencing technologies and their applications in research, applied and clinical segments
  • Analysis of the global market trends, with data from 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
  • A market forecast for the DNA sequencing industry, and a corresponding market share analysis by products and services, end-use segment, application, disease category and region
  • A look at the key market dynamics for DNA sequencing, and the regulatory scenario
  • Discussion of market opportunities for DNA sequencing, industry structure, applications and business considerations of sequencing technologies, along with the ongoing changes in the structure of the MedTech industry
  • Review of the leading next-generation sequencing (NGS) technologies, emerging applications, and the DNA sequencing-based diagnostics and research initiatives affecting the market
  • Analysis of patents related to novel sequencing technologies, as well as clinical trials
  • A discussion of ESG challenges and ESG practices in the industry
  • Insights into the major acquisitions and strategic alliances, competitive benchmarking of sequencing industry participants and their growth strategies
  • Market share analysis of the leading companies, as well as company profiles, including Illumina Inc., Thermo Fisher Scientific Inc., Pacific Biosciences (PacBio), and Oxford Nanopore Technologies Ltd.

Table of Contents

Chapter 1 Executive Summary

  • Market Outlook
  • Scope of Report
  • Market Insights

Chapter 2 Market Overview

  • Importance of DNA
  • Genetic Variation and Analysis
  • History of Sequencing
  • NGS (Second-generation Sequencing)
  • TGS (Long-read Sequencing)
  • Research and Applied Applications
  • R&D Applications
  • Applied Applications
  • Direct to Consumer
  • Biopharma
  • Agriculture
  • Forensics
  • Microbiome
  • Synthetic Biology

Chapter 3 Market Dynamics

  • Market Dynamics Snapshot
  • Market Drivers
  • Technological Advances in Sequencing Techniques
  • Rising Applications of DNA Sequencing in Clinical Diagnostics
  • Market Restraints
  • High Cost of DNA Sequencing
  • Data Interpretation and Management Challenges
  • Market Opportunities
  • Expansion of Precision Medicine
  • Growth in NIPT

Chapter 4 Emerging Technologies

  • Long-read Sequencing Technologies
  • SMRT Sequencing
  • Nanopore Sequencing
  • Spatial Genomics and Transcriptomics
  • Single-cell DNA Sequencing
  • Ultra-low Input Sequencing
  • CRISPR-Cas9 and Genome-editing Integration with Sequencing Technologies
  • AI and Machine Learning in DNA Sequencing

Chapter 5 Market Segmentation Analysis

  • Segmentation Breakdown
  • Global DNA Sequencing Market Analysis by Product and Service
  • Instruments and Consumables
  • Services
  • Global DNA Sequencing Market Analysis by Technology
  • NGS
  • TGS
  • Sanger Sequencing
  • Pyrosequencing
  • Global DNA Sequencing Market Analysis by Application
  • Biopharma
  • Microbiology
  • Agriculture
  • Others (Synthetic Biology, Population Genomics, and Consumer Genomics)
  • Global DNA Sequencing Market Analysis by End User
  • Market Size and Forecast
  • Academic and Research Institutes
  • Hospitals and Clinics
  • Pharmaceutical and Biotechnology Companies
  • Clinical Research
  • Others (Agricultural Institutions, Forensic Labs)
  • Global DNA Sequencing Market Analysis by Disease Category
  • Market Size and Forecast
  • Cancer
  • Reproductive Health
  • Mendelian Disorders
  • Others (Cardiology, Metabolic/Immune, Neurology, Transplant, Clinical)
  • Geographic Breakdown
  • Global DNA Sequencing Market Analysis by Region
  • Market Size and Forecast
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

Chapter 6 Competitive Landscape

  • Overview
  • Partnerships
  • Investments and Funding
  • Patent Analysis

Chapter 7 ESG Perspective

  • Introduction
  • ESG Performance in the Market
  • ESG Practices in the DNA Sequencing Industry
  • Environmental Performance
  • Social Performance
  • Governance Performance
  • ESG Risk Ratings in the DNA Sequencing Industry
  • Concluding Remarks from BCC Research

Chapter 8 Appendix

  • Methodology
  • Sources
  • Abbreviations
  • Company Profiles
  • AGILENT TECHNOLOGIES INC.
  • BGI
  • F. HOFFMANN-LA ROCHE LTD.
  • GUARDANT HEALTH
  • ILLUMINA INC.
  • MYRIAD GENETICS INC.
  • OXFORD NANOPORE TECHNOLOGIES PLC.
  • PACBIO
  • QIAGEN
  • THERMO FISHER SCIENTIFIC INC.
  • Other Key Companies Offering DNA Sequencing Services
  • 10X GENOMICS
  • CROWN BIOSCIENCE
  • EUROFINS GENOMICS
  • GENEWIZ, FROM AZENTA LIFE SCIENCES
  • INTEGRATED DNA TECHNOLOGIES, INC
  • MACROGEN
  • NOVOGENE CO., LTD.
  • REVVITY

List of Tables

  • Summary Table : Global DNA Sequencing Market, by Region, Through 2029
  • Table 1 : DNA Chemical Building Blocks
  • Table 2 : DNA Transcription and Translation
  • Table 3 : Long-range DNA Structure
  • Table 4 : Types of Genetic Variation
  • Table 5 : Molecular Diagnostic Technology Platforms
  • Table 6 : Genome Coverage of PCR, Microarray, and NGS Technology Platforms
  • Table 7 : DNA Sequencing Historical Timeline, 1970s to Present
  • Table 8 : Main Sequencing Applications
  • Table 9 : Genetic Analysis Platform Comparison
  • Table 10 : Sequencing Impact on Agricultural Product Classes
  • Table 11 : Key Applications in Forensics/Human Identity Sequencing
  • Table 12 : Key Applications in Microbial Sequencing
  • Table 13 : Global DNA Sequencing Market, by Product and Service, Through 2029
  • Table 14 : DNA Sequencing Instruments and Consumables Offered by Major Companies
  • Table 15 : Global DNA Sequencing Market for Instruments and Consumables, by Region, Through 2029
  • Table 16 : Global DNA Sequencing Market for Instruments and Consumables, by Workflow Component, Through 2029
  • Table 17 : Classification of Sequencing Instruments Based on Capacity, Sequencing Capabilities, Read Length, and Application
  • Table 18 : Global DNA Sequencing Market for Instruments, by Region, Through 2029
  • Table 19 : Global DNA Sequencing Market for Kits and Reagents, by Region, Through 2029
  • Table 20 : Global DNA Sequencing Market for Services, by Region, Through 2029
  • Table 21 : Global DNA Sequencing Market for Services, by Workflow Component, Through 2029
  • Table 22 : Global DNA Sequencing Market for Services, by Region, Through 2029
  • Table 23 : Global DNA Sequencing Market for Software and Informatics Solutions, by Region, Through 2029
  • Table 24 : Global DNA Sequencing Market, by Technology, Through 2029
  • Table 25 : Global NGS Market, by Region, Through 2029
  • Table 26 : Different Generations of NGS platforms
  • Table 27 : Global TGS Market, by Region, Through 2029
  • Table 28 : Global Sanger Sequencing Market, by Region, Through 2029
  • Table 29 : Global Pyrosequencing Market, by Region, Through 2029
  • Table 30 : Global DNA Sequencing Market, by Application, Through 2029
  • Table 31 : Global DNA Sequencing Market in Biopharma, by Region, Through 2029
  • Table 32 : Global DNA Sequencing Market in Microbiology, by Region, Through 2029
  • Table 33 : Global DNA Sequencing Market in Agriculture, by Region, Through 2029
  • Table 34 : Global DNA Sequencing Market in Other Applications (Synthetic Biology, Population Genomics, and Consumer Genomics), by Region, Through 2029
  • Table 35 : Global DNA Sequencing Market, by End User, Through 2029
  • Table 36 : Global DNA Sequencing Market for Academic and Research Institutes, by Region, Through 2029
  • Table 37 : Global DNA Sequencing Market for Hospitals and Clinics, by Region, Through 2029
  • Table 38 : Global DNA Sequencing Market for Pharmaceutical and Biotechnology Companies, by Region, Through 2029
  • Table 39 : Global DNA Sequencing Market for Clinical Research, by Region, Through 2029
  • Table 40 : Key Applications in Forensics/Human Identity Sequencing
  • Table 41 : Global DNA Sequencing Market for Other End Users, by Region, Through 2029
  • Table 42 : Global DNA Sequencing Market, by Disease Category, Through 2029
  • Table 43 : Global DNA Sequencing Market for Cancer, by Region, Through 2029
  • Table 44 : Global DNA Sequencing Market for Reproductive Health, by Region, Through 2029
  • Table 45 : Global DNA Sequencing Market for Mendelian Disorders, by Region, Through 2029
  • Table 46 : Global DNA Sequencing Market for Other Diseases, by Region, Through 2029
  • Table 47 : Global DNA Sequencing Market, by Region, Through 2029
  • Table 48 : North American DNA Sequencing Market, by Country, Through 2029
  • Table 49 : North American DNA Sequencing Market, by Product and Service, Through 2029
  • Table 50 : North American DNA Sequencing Market for Instruments and Consumables, by Workflow Component, Through 2029
  • Table 51 : North American DNA Sequencing Market for Services, by Workflow Component, Through 2029
  • Table 52 : North American DNA Sequencing Market, by Technology, Through 2029
  • Table 53 : North American DNA Sequencing Market, by Application, Through 2029
  • Table 54 : North American DNA Sequencing Market, by End User, Through 2029
  • Table 55 : North American DNA Sequencing Market, Category, Through 2029
  • Table 56 : European DNA Sequencing Market, by Country, Through 2029
  • Table 57 : European DNA Sequencing Market, by Product and Service, Through 2029
  • Table 58 : European DNA Sequencing Market for Instruments and Consumables, by Workflow Component, Through 2029
  • Table 59 : European DNA Sequencing Market for Services, by Workflow Component, Through 2029
  • Table 60 : European DNA Sequencing Market, by Technology, Through 2029
  • Table 61 : European DNA Sequencing Market, by Application, Through 2029
  • Table 62 : European DNA Sequencing Market, by End User, Through 2029
  • Table 63 : European DNA Sequencing Market, by Disease Category, Through 2029
  • Table 64 : Asia-Pacific DNA Sequencing Market, by Country, Through 2029
  • Table 65 : Asia-Pacific DNA Sequencing Market, by Product and Service, Through 2029
  • Table 66 : Asia-Pacific DNA Sequencing Market for Instruments and Consumables, by Workflow Component, Through 2029
  • Table 67 : Asia-Pacific DNA Sequencing Market for Services, by Workflow Component, Through 2029
  • Table 68 : Asia-Pacific DNA Sequencing Market, by Technology, Through 2029
  • Table 69 : Asia-Pacific DNA Sequencing Market, by Application, Through 2029
  • Table 70 : Asia-Pacific DNA Sequencing Market, by End User, Through 2029
  • Table 71 : Asia-Pacific DNA Sequencing Market, by Disease Category, Through 2029
  • Table 72 : RoW DNA Sequencing Market, by Product and Service, Through 2029
  • Table 73 : RoW DNA Sequencing Market for Instruments and Consumables, by Workflow Component, Through 2029
  • Table 74 : RoW DNA Sequencing Market for Services, by Workflow Component, Through 2029
  • Table 75 : RoW DNA Sequencing Market, by Technology, Through 2029
  • Table 76 : RoW DNA Sequencing Market, by Application, Through 2029
  • Table 77 : RoW DNA Sequencing Market, by End User, Through 2029
  • Table 78 : RoW DNA Sequencing Market, by Disease Category, Through 2029
  • Table 79 : Top DNA Sequencing Companies, 2023
  • Table 80 : Select Strategic Alliances in the DNA Sequencing Industry, 2022-2024
  • Table 81 : Major Funding Activities in the DNA Sequencing Industry, 2023 and 2024
  • Table 82 : Active Patents of Key Competitor Companies, 2024
  • Table 83 : Key Focus Areas in ESG Metrics
  • Table 84 : Environmental Performance Initiatives in the DNA Sequencing Market
  • Table 85 : Social Performance Initiatives in DNA Sequencing Market
  • Table 86 : Governance Performance Initiatives in DNA Sequencing Market
  • Table 87 : ESG Rankings for Key Players in DNA Sequencing Market, 2024*
  • Table 88 : Information Sources in This Report
  • Table 89 : Abbreviations Used in the DNA Sequencing Market
  • Table 90 : Agilent Technologies Inc.: Company Snapshot
  • Table 91 : Agilent Technologies Inc.: Financial Performance, FY 2022 and 2023
  • Table 92 : Agilent Technologies Inc.: Product Portfolio
  • Table 93 : Agilent Technologies Inc.: News/Key Developments, 2023
  • Table 94 : BGI: Company Snapshot
  • Table 95 : BGI: Financial Performance, FY 2022 and 2023
  • Table 96 : BGI: Product Portfolio
  • Table 97 : F. Hoffmann-La Roche Ltd.: Company Snapshot
  • Table 98 : F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2022 and 2023
  • Table 99 : F. Hoffmann-La Roche Ltd.: Product Portfolio
  • Table 100 : F. Hoffmann-La Roche Ltd.: News/Key Developments, 2022-2024
  • Table 101 : Guardant Health: Company Snapshot
  • Table 102 : Guardant Health: Financial Performance, FY 2022 and 2023
  • Table 103 : Guardant Health: Product Portfolio
  • Table 104 : Guardant Health: News/Key Developments, 2022-2024
  • Table 105 : Illumina Inc.: Company Snapshot
  • Table 106 : Illumina Inc.: Financial Performance, FY 2022 and 2023
  • Table 107 : Illumina Inc.: Product Portfolio
  • Table 108 : Illumina Inc.: News/Key Developments, 2023 and 2024
  • Table 109 : Myriad Genetics Inc.: Company Snapshot
  • Table 110 : Myriad Genetics Inc.: Financial Performance, FY 2022 and 2023
  • Table 111 : Myriad Genetics Inc.: Product Portfolio
  • Table 112 : Myriad Genetics Inc.: News/Key Developments, 2023
  • Table 113 : Oxford Nanopore Technologies plc.: Company Snapshot
  • Table 114 : Oxford Nanopore Technologies plc.: Financial Performance, FY 2022 and 2023
  • Table 115 : Oxford Nanopore Technologies plc.: Product Portfolio
  • Table 116 : Oxford Nanopore Technologies plc.: News/Key Developments, 2024
  • Table 117 : PacBio: Company Snapshot
  • Table 118 : PacBio: Financial Performance, FY 2022 and 2023
  • Table 119 : PacBio: Product Portfolio
  • Table 120 : PacBio: News/Key Developments, 2023 and 2024
  • Table 121 : Qiagen: Company Snapshot
  • Table 122 : Qiagen: Financial Performance, FY 2022 and 2023
  • Table 123 : Qiagen: Product Portfolio
  • Table 124 : Qiagen: News/Key Developments, 2023 and 2024
  • Table 125 : Thermo Fisher Scientific Inc.: Company Snapshot
  • Table 126 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
  • Table 127 : Thermo Fisher Scientific Inc.: Product Portfolio
  • Table 128 : Thermo Fisher Scientific Inc.: News/Key Developments, 2023 and 2024

List of Figures

  • Summary Figure : Global DNA Sequencing Market Shares, by Region, 2023
  • Figure 1 : Evolution of Sequencing Technologies, 1975-2015
  • Figure 2 : Snapshot of Market Dynamics for DNA Sequencing
  • Figure 3 : Global DNA Sequencing Market Shares, by Product and Service, 2023
  • Figure 4 : Global DNA Sequencing Market for Instruments and Consumables, by Region, 2021-2029
  • Figure 5 : Global DNA Sequencing Market for Services, by Region, 2021-2029
  • Figure 6 : Global DNA Sequencing Market Shares, by Technology, 2023
  • Figure 7 : Different NGS Technologies and Their Applications
  • Figure 8 : Global NGS Market, 2021-2029
  • Figure 9 : Global NGS Market, by Region, 2021-2029
  • Figure 10 : Global TGS Market, 2021-2029
  • Figure 11 : Global TGS Market, by Region, 2021-2029
  • Figure 12 : Global Sanger Sequencing Market, 2021-2029
  • Figure 13 : Global Sanger Sequencing Market, by Region, 2021-2029
  • Figure 14 : Global Pyrosequencing Market, 2021-2029
  • Figure 15 : Global Pyrosequencing Market, by Region, 2021-2029
  • Figure 16 : Global DNA Sequencing Market Shares, by Application, 2023
  • Figure 17 : Global DNA Sequencing Market in Biopharma, 2021-2029
  • Figure 18 : Global DNA Sequencing Market in Microbiology, 2021-2029
  • Figure 19 : Global DNA Sequencing Market in Agriculture, 2021-2029
  • Figure 20 : Global DNA Sequencing Market in Other Applications (Synthetic Biology, Population Genomics, and Consumer Genomics), 2021-2029
  • Figure 21 : Global DNA Sequencing Market Shares, by End User, 2023
  • Figure 22 : Global DNA Sequencing Market for Academic and Research Institutes, 2021-2029
  • Figure 23 : Global DNA Sequencing Market for Hospitals and Clinics, 2021-2029
  • Figure 24 : Global DNA Sequencing Market for Pharmaceutical and Biotechnology Companies, 2021-2029
  • Figure 25 : Global DNA Sequencing Market for Clinical Research, 2021-2029
  • Figure 26 : Global DNA Sequencing Market for Other End Users, 2021-2029
  • Figure 27 : Global DNA Sequencing Market Shares, by Disease Category, 2023
  • Figure 28 : Global DNA Sequencing Market for Cancer, 2021-2029
  • Figure 29 : Global DNA Sequencing Market for Reproductive Health, 2021-2029
  • Figure 30 : Global DNA Sequencing Market for Mendelian Disorders, 2021-2029
  • Figure 31 : Global DNA Sequencing Market for Other Diseases, 2021-2029
  • Figure 32 : Global DNA Sequencing Market Shares, by Region, 2023
  • Figure 33 : Global DNA Sequencing Market, by Region, 2021-2029
  • Figure 34 : North American DNA Sequencing Market Shares, by Country, 2023
  • Figure 35 : The U.S. DNA Sequencing Market, 2021-2029
  • Figure 36 : Canadian DNA Sequencing Market, 2021-2029
  • Figure 37 : Mexican DNA Sequencing Market, 2021-2029
  • Figure 38 : European DNA Sequencing Market Shares, by Country, 2023
  • Figure 39 : German DNA Sequencing Market, 2021-2029
  • Figure 40 : The U.K. DNA Sequencing Market, 2021-2029
  • Figure 41 : French DNA Sequencing Market, 2021-2029
  • Figure 42 : Italian DNA Sequencing Market, 2021-2029
  • Figure 43 : Spanish DNA Sequencing Market, 2021-2029
  • Figure 44 : Rest of European DNA Sequencing Market, 2021-2029
  • Figure 45 : Asia-Pacific DNA Sequencing Market Shares, by Country, 2023
  • Figure 46 : Chinese DNA Sequencing Market, 2021-2029
  • Figure 47 : Japanese DNA Sequencing Market, 2021-2029
  • Figure 48 : Indian DNA Sequencing Market, 2021-2029
  • Figure 49 : Australian DNA Sequencing Market, 2021-2029
  • Figure 50 : South Korean DNA Sequencing Market, 2021-2029
  • Figure 51 : Rest of Asia-Pacific DNA Sequencing Market, 2021-2029
  • Figure 52 : Snapshot of ESG Pillars
  • Figure 53 : Advantages of ESG for Companies
  • Figure 54 : Share of Biotech Companies Providing ESG Disclosure, 2022
  • Figure 55 : Share of Biotech Companies Providing ESG Disclosure, by Disclosure Type, 2022
  • Figure 56 : Agilent Technologies Inc.: Revenue Share, by Business Unit, FY 2023
  • Figure 57 : Agilent Technologies Inc.: Revenue Share, by Country/Region, FY 2023
  • Figure 58 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, FY 2023
  • Figure 59 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Country/Region, FY 2023
  • Figure 60 : Guardant Health: Revenue Share, by Business Unit, FY 2023
  • Figure 61 : Guardant Health: Revenue Share, by Country/Region, FY 2023
  • Figure 62 : Illumina Inc.: Revenue Share, by Business Unit, FY 2023
  • Figure 63 : Illumina Inc.: Revenue Share, by Country/Region, FY 2023
  • Figure 64 : Myriad Genetics Inc.: Revenue Share, by Business Unit, FY 2023
  • Figure 65 : Myriad Genetics Inc.: Revenue Share, by Country/Region, FY 2023
  • Figure 66 : Oxford Nanopore Technologies plc.: Revenue Share, by Business Unit, FY 2023
  • Figure 67 : Oxford Nanopore Technologies plc.: Revenue Share, by Country/Region, FY 2023
  • Figure 68 : PacBio: Revenue Share, by Business Unit, FY 2023
  • Figure 69 : PacBio: Revenue Share, by Country/Region, FY 2023
  • Figure 70 : Qiagen: Revenue Share, by Business Unit, FY 2023
  • Figure 71 : Qiagen: Revenue Share, by Country/Region, FY 2023
  • Figure 72 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2023
  • Figure 73 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, FY 2023